Hepatocyte-specific and extra-hepatocyte actions of perilipin-2 during fatty liver disease: benefits of being extra
J Physiol
.
2019 Mar;597(6):1431-1432.
doi: 10.1113/JP277539.
Epub 2019 Jan 29.
Authors
Lindsey Kennedy
1
,
Heather Francis
2
1
,
Gianfranco Alpini
2
1
Affiliations
1
Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
2
Research, Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA.
PMID:
30656685
PMCID:
PMC6418740
DOI:
10.1113/JP277539
No abstract available
Keywords:
NAFLD; NASH; Perilipin-2; Steatosis.
Publication types
Comment
MeSH terms
Animals
Fatty Liver*
Hepatocytes*
Mice
Obesity
Perilipin-2
Substances
Perilipin-2
Grants and funding
R01 DK108959/DK/NIDDK NIH HHS/United States
R21 AA025997/AA/NIAAA NIH HHS/United States